Always consult with a qualified healthcare provider before starting any peptide protocol.] Most people overthink GHK-Cu dosing, either wasting their money on sub-optimally concentrated solutions or jumping straight into aggressive high-dose protocols
The FDA does not review compounded drugs for safety, effectiveness, or quality
Importantly, TA1 is not approved by the FDA for autoimmune treatment, so patients should seek medical supervision and consider legal implications
Copper tripeptide-1 (GHK-Cu) is the most studied copper peptide, originally isolated from human plasma and proposed to promote dermal papilla cell activity and VEGF-driven scalp vascularity
Scott Brunner, CEO of Alliance for Pharmacy Compounding, concluded: With this new state-of-the-art facility, theyre not only increasing capacity, but also elevating compliance and safety and most importantly the care they provide patients.